Dr. Rebecca Krimins is an Assistant Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science, with additional appointments in the Department of Anesthesiology and Critical Care Medicine and the Department of Molecular and Comparative Pathobiology. A native of Annapolis, Maryland, Dr. Krimins completed her veterinary anesthesia and analgesia residency at the Purdue University School of Veterinary Medicine. Dr. Krimins has more than 15 years of experience in managing critically ill patients during advanced imaging procedures and conducting cutting-edge clinical studies. Dr. Krimins’ specialty in veterinary anesthesia, sedation and pain management in combination with her experience in directing advanced clinical research offers each veterinary patient the best opportunities for diagnosis and therapy. Dr. Krimins works closely with each patient's personal veterinarian and pet family to ensure accurate and timely results that are crucial for therapeutic options. The Veterinary Clinical Trials Network at Johns Hopkins University is designed to leverage the expertise and platforms available at Johns Hopkins University in order to transform newly discovered diagnostics and therapeutics into real-life practical approaches that benefit veterinary patients
The inclusion of naturally occurring disease in pet animals is an attractive and increasingly recognized approach to model our understanding of the biology, prevention and therapy of human disease. In this text, successful examples of this cross-species approach are reviewed in a variety of therapeutic areas, including the notable progress in oncology. -- Chand Khanna, DVM, PhD, DACVIM (Onc), DACVP (Hon), Chief Science Officer, Ethos Veterinary Health, and President, Ethos Discovery The inclusion of naturally occurring disease in pet animals is an attractive and increasingly recognized approach to model our understanding of the biology, prevention and therapy of human disease. In this text, successful examples of this cross-species approach are reviewed in a variety of therapeutic areas, including the notable progress in oncology. -- Chand Khanna, DVM, PhD, DACVIM (Onc), DACVP (Hon), Chief Science Officer, Ethos Veterinary Health, and President, Ethos Discovery